Wiktorin Anna C H, Dafgård Kopp Eva M E, Tani Edneia, Söderén Boel, Allen Richard C
Department of Oculoplastic and Orbital Service, St Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden.
Department of Pathology and Cytology, Karolinska University Hospital, Karolinska Institutet, Solna, Sweden.
Am J Ophthalmol. 2016 Jun;166:37-42. doi: 10.1016/j.ajo.2016.03.021. Epub 2016 Mar 23.
To describe and analyze results from the fine-needle aspiration biopsy (FNAB) technique, used as a diagnostic tool, in patients with orbital lesions.
Retrospective case series.
setting: Institutional (Karolinska Hospital, Stockholm).
207 patients with 210 orbital lesions.
225 FNABs of the orbit.
Successful diagnosis from FNAB.
Of the 210 orbital lesions evaluated with FNAB, a successful cytologic diagnosis was achieved in 176 (84%). In more than half of the orbital lesions (54%), the FNAB diagnosis in addition to imaging appearance, clinical appearance, and clinical history provided sufficient information for treatment, and the patient did not require an incisional or excisional biopsy. Ninety-seven patients underwent additional excisional or incisional biopsy; FNAB diagnoses and the histopathologic diagnoses corresponded in 87% of the cases with an intraclass correlation coefficient of 0.84 (95% confidence interval [CI] 0.76-0.90). The difference was statistically significant between the ability to make a successful cytologic FNAB diagnosis in palpable lesions vs nonpalpable lesions (successful diagnosis in 90% [CI = 85%-95%] vs 75% [CI = 66%-84%]; P < .01). Neither the orbital quadrant location, nor the radiologic appearance (diffuse vs encapsulated), nor size of the lesion affected the success of FNAB diagnoses (all P > .7). There was a complication in 6 cases (3%). All complications were temporary and none led to permanent damage.
FNAB proved effective and exceedingly safe. With the current healthcare climate of minimally invasive surgery and cost control, FNAB should be considered as a valid alternative to open surgery in the evaluation and management of orbital lesions.
描述并分析细针穿刺活检(FNAB)技术作为诊断工具在眼眶病变患者中的应用结果。
回顾性病例系列研究。
研究地点:机构研究(斯德哥尔摩卡罗林斯卡医院)。
207例患者,共210处眼眶病变。
对眼眶进行225次FNAB检查。
通过FNAB获得成功诊断。
在210处接受FNAB评估的眼眶病变中,176处(84%)获得了成功的细胞学诊断。超过半数的眼眶病变(54%)中,除影像学表现、临床表现和临床病史外,FNAB诊断还为治疗提供了足够的信息,患者无需进行切开活检或切除活检。97例患者接受了额外的切除活检或切开活检;FNAB诊断与组织病理学诊断在87%的病例中相符,组内相关系数为0.84(95%置信区间[CI] 0.76 - 0.90)。可触及病变与不可触及病变在进行成功的FNAB细胞学诊断能力上的差异具有统计学意义(成功诊断率分别为90% [CI = 85% - 95%]和75% [CI = 66% - 84%];P <.01)。眼眶象限位置、放射学表现(弥漫性与包膜性)以及病变大小均未影响FNAB诊断的成功率(所有P >.7)。有6例(3%)出现并发症。所有并发症均为暂时性,无一导致永久性损害。
FNAB被证明是有效且极其安全的。在当前微创手术和成本控制的医疗环境下,FNAB应被视为眼眶病变评估和管理中开放手术的有效替代方法。